entity

disease onset

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about disease onset: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9Connections

0Hypotheses

3Analyses

0Outgoing

9Incoming

0Experiments

5Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (9)

Source	Relation	Type	Str
38609352	is the driver of	paper	0.90
34145375	delays	paper	0.90
34857917	significantly delayed	paper	0.90
GENETIC MODIFIERS	modulates	gene	0.85
Sex Differences	contributes_to	phenotype	0.85
Sex Differences In Autophagy	contributes_to	mechanism	0.80
PRKCG	promotes	gene	0.80
Sex	modulates	mechanism	0.70
Plasma Aβ42/40	predicts	biomarker	0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (3)

Scientific analyses that reference this entity

Polygenic Risk Score Analysis for Late-Onset Alzheimer's Disease

neurodegeneration | 2026-04-16 | 1 hypotheses

Multi-modal Biomarker Panel Design for Early AD Detection

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.559

What molecular mechanisms drive microglial senescence and the transition to dyst

neurodegeneration | 2026-04-06 | 7 hypotheses Top: 0.800

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (5)

Multi-agent debates referencing this entity

The abstract identifies dystrophic microglia as senescent cells in aged brains b

closed · Rounds: 4 · Score: 0.79 · 2026-04-22

Can a multi-modal biomarker panel combining plasma proteins, neuroimaging featur

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

How well do current AD polygenic risk scores predict disease onset in independen

closed · Rounds: 4 · Score: 0.50 · 2026-04-21

Are AD polygenic risk scores ready for clinical use in risk stratification, or d

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Should clinical practice adopt multi-modal biomarker panels now, or wait for sin

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning disease onset in their description or question text

No additional research found